Skip to content

Benzodiazcfmmethur

Published: August 9, 2026Updated: August 16, 2026

A confirmatory urine test to detect benzodiazepines, a class of prescription medications used for anxiety and sleep disorders.

Quick summary

{"This test confirms the presence of benzodiazepine drugs in urine","It is often used after a positive screening test to verify results","Benzodiazepines include common medications like Valium, Xanax, and Ativan","The test detects drug metabolites that remain in urine for days after use","Results help healthcare providers monitor medication use or investigate potential misuse"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
19286-4
Short code
BENZOC
Synonyms
Benzodiaz Cfm Meth Ur
Category
chemistry
Sample
urine
Container
Sterile, leak-proof urine collection container without preservatives; preferably a tamper-evident container for chain-of-custody specimens
Units
N/A
Ref low
100
Ref high
300
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
Confirmatory method such as Gas Chromatography-Mass Spectrometry (GC-MS) or Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
CPT
80346
SNOMED
442121009
Specimen volume
30-50 mL
Stability
Room temperature: 48 hours; Refrigerated (2-8°C): 7 days; Frozen (-20°C or below): 30 days for forensic specimens
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
24–72 hours
Order
routine

What is this test?

The Benzodiazepines Confirmatory Test in Urine is a laboratory test that detects the presence of benzodiazepines and their metabolites in a urine sample. Benzodiazepines are a class of prescription medications commonly prescribed for anxiety, insomnia, muscle relaxation, and seizure control. Common benzodiazepines include diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin), and temazepam (Restoril).

This is a confirmatory test, meaning it is typically performed after an initial screening test shows a positive result. Confirmatory tests use more sophisticated methods to specifically identify which benzodiazepine is present and verify the screening result. The test detects drug metabolites—the substances your body produces when it breaks down the medication—which can remain in urine for several days after use.

Reference range

Not applicable (qualitative or semi-quantitative confirmatory test); cutoff threshold typically 100-300 ng/mL depending on specific benzodiazepine analyteN/A

Specimen: urine

No special preparation required. Patient should be informed of the purpose of the test, and written consent may be required for forensic or workplace testing. Patients should provide a complete medication history including prescription benzodiazepines, as these may cause positive results.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

This test is primarily used to verify positive screening results for benzodiazepines. Healthcare providers may order this test for several reasons: to monitor patients on benzodiazepine therapy and ensure proper medication use, to investigate suspected drug misuse or overdose, to evaluate patients presenting with symptoms of benzodiazepine intoxication or withdrawal, or as part of a comprehensive drug testing panel for employment, legal, or medical purposes.

Understanding the specific benzodiazepine present helps healthcare providers make informed decisions about patient care, including dosage adjustments, treatment planning, or addressing potential dependency issues. The test can also help distinguish between legitimate prescription use and unauthorized drug use.

Frequently asked questions

How is this test different from a benzodiazepine screening test?
A screening test is a preliminary test that can indicate whether benzodiazepines may be present, but it may not identify the specific drug. This confirmatory test uses more advanced laboratory methods (such as gas chromatography-mass spectrometry or liquid chromatography-tandem mass spectrometry) to precisely identify which benzodiazepine or metabolites are present and verify the initial screening result.
How long do benzodiazepines stay in urine?
The detection window varies depending on the specific benzodiazepine, dosage, frequency of use, and individual metabolism. Generally, benzodiazepines can be detected in urine for 1-7 days after last use. Long-acting benzodiazepines like diazepam may be detectable longer than short-acting ones like alprazolam.
Do I need to prepare for this test?
No special preparation is typically required. You should inform your healthcare provider about all medications, supplements, and herbal products you are taking, as some substances may affect test results. Follow any specific instructions provided by your healthcare provider or the testing facility.
Can this test detect prescription use versus misuse?
This test can detect the presence of benzodiazepines but cannot distinguish between prescribed use and misuse on its own. Your healthcare provider will interpret the results in the context of your medical history, prescribed medications, and clinical presentation to determine whether the results are consistent with your prescribed regimen.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy